Foreign U.S. Treasury Holdings Fall as Japan, UK and China Cut Positions 
Trump Imposes New Tariffs on Drone Imports Over US Security Concerns 
Gold Prices Rise as Markets Await Trump’s Policy Announcements 
Morgan Stanley Sees Fed Holding Rates as U.S. Inflation Cools 
Canada Faces 50% U.S. Tariffs as Trade Tensions Threaten USMCA Talks 
Ferrari Group to Launch IPO in Amsterdam, Targets Over $1 Billion Valuation 
Insignia Financial Shares Hit 3-Year High Amid Bain and CC Capital Bidding War 
Infosys Shares Drop Amid Earnings Quality Concerns 
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth 
U.S. Stock Futures Rise as Trump Takes Office, Corporate Earnings Awaited 
Oil Prices Rise as Iran-U.S. Tensions Threaten Strait of Hormuz Supply 
US Stock Futures Steady as Cooling Inflation and Strong Earnings Support Markets 
China’s Growth Faces Structural Challenges Amid Doubts Over Data 
Citadel Warns High Treasury Yields Pose Broader Market Risks 
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors 
US Dollar Hovers Near Multi-Month Lows as Fed Rate Hike Bets Ease 
Colombia Earthquake Losses Estimated at $9.58 Billion as Reconstruction Challenge Mounts 
Add as a preferred source on Google
While South Korean investors made Tesla a top pick among US-listed stocks with combined holdings of $9.7 billion as of Aug. 10, many had begun selling off shares in the world’s largest electric car maker in June while turning to vaccine-related stocks, including Moderna.
In June, South Korean investors sold $811 million worth of Tesla shares worthwhile purchasing $784.3 million, according to data compiled by the Korea Securities Depository.
It marked the first month since December 2019 in which there were more South Korean sellers than buyers of Tesla stock.
The trend continued in July with South Koreans selling Tesla shares amounting to $756.8 million, out sizing purchases of $716.1 million.
From Aug. 1 to 10, sales of Tesla stocks by South Koreans were equal to their purchases, both at $356.6 million.
South Koreans were also selling off Ark Innovation ETF, an exchange-traded fund product called popular for its 10 percent weighting in Tesla.
Since March, South Korean traders had divested $400 million worth of the flagship active ETF product from Ark Invest while purchasing just over $260 million during the same period.
South Korean investors purchased $430 million worth of Moderna stocks from July to Aug. 10, making it the fourth-largest US-listed stock after Tesla, Amazon, and Apple. Meanwhile, they sold $368 million worth of the said stock.
Consequently, Moderna’s stock price more than doubled over the last six months.
South Koreans also favored other vaccine stocks with Novavax and Pfizer making it in the top 50 list.
South Korean investors bought $32.1 billion worth of US-listed shares from June through Thursday while selling less than $30.4 billion.
